CLEAR-B: Eine Studie zur Bewertung der endokrinen therapeutischen Präferenzen und Ergebnisse für prämenopausale Patientinnen mit Brustkrebs im Frühstadium mit mittlerem und hohem Rezedivrisiko

Explorative Studie zum therapeutischen Fasten zur Reduktion von Einschränkungen des körperlichen Befindens und der Lebensqualität unter Endokriner Therapie mit Aromatase Inhibitoren

Establishment of a national registry for the Evaluation and improvement of Risk-adjusted prevention for hereditary breast and ovarian cancer

Identifikation der Pathomechanismen der Medikamenten-assoziierten Kieferosteonekrose als Grundlage zur Prophylaxe und Therapie

Phase II neoadjuvant study evaluating capivasertib plus fulvestrant vs fulvestrant in patients with with primary high-risk lobular breast cancer - LOBSTER

A Prospective Non-interventional Multicenter Cohort Study to Evaluate Different Imaging-guided Methods for Localization of Non-palpable Malignant Breast Lesions [EUBREAST-4]

Abemaciclib and endocrine therapy in hormone receptor positive HER2 negative locally advanced or metastatic breast cancer with focos on digital side effect management

Comprehensive assessment of clinical features and biomarkers to identify patients with advanced or metastatic breast cancer for marker driven trials in humans (CATCH).

Comprehensive assessment of clinical features, genomics and further molecular markers to identify patients with early breast cancer for enrolment on marker driven trials (COGNITION)

A Phase I clinical trial to assess safety and tolerability of autologous ROR1 CAR-T cells in ROR1+ tumors